These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14999741)

  • 21. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
    Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
    Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
    Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
    Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.
    Matilainen L; Järvinen K; Toropainen T; Näsi E; Auriola S; Järvinen T; Jarho P
    Int J Pharm; 2006 Aug; 318(1-2):41-8. PubMed ID: 16624508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols.
    Hoye WL; Mogalian EM; Myrdal PB
    Am J Health Syst Pharm; 2005 Nov; 62(21):2271-7. PubMed ID: 16239418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.
    D'Sa D; Chan HK
    Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability.
    Tzou TZ; Pachuta RR; Coy RB; Schultz RK
    J Pharm Sci; 1997 Dec; 86(12):1352-7. PubMed ID: 9423144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.
    Martin AR; Kwok DY; Finlay WH
    J Aerosol Med; 2005; 18(2):218-24. PubMed ID: 15966776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
    Saleem IY; Smyth HD
    Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.
    Tam JM; Engstrom JD; Ferrer D; Williams RO; Johnston KP
    J Pharm Sci; 2010 Jul; 99(7):3150-65. PubMed ID: 20187139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug.
    Shaik MS; Haynes A; McSween J; Ikediobi O; Kanikkannan N; Singh M
    J Aerosol Med; 2002; 15(3):261-70. PubMed ID: 12396414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
    Berry J; Kline LC; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
    Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
    Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants.
    Tan Y; Yang Z; Peng X; Xin F; Xu Y; Feng M; Zhao C; Hu H; Wu C
    Int J Pharm; 2011 Jul; 413(1-2):167-73. PubMed ID: 21527322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of a protein with propellant HFA 134a for aerosol delivery.
    Williams RO; Liu J
    Eur J Pharm Sci; 1999 Jan; 7(2):137-44. PubMed ID: 9845798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants.
    Nyambura BK; Kellaway IW; Taylor KM
    Int J Pharm; 2009 May; 372(1-2):140-6. PubMed ID: 19429273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers.
    Bachhav SS; Sheth P; Sandell D; Svensson M; Bhagwat S; Conti DS; Oguntimein O; Dhapare S; Saluja B; Winner L; Bulitta JB; Hochhaus G
    AAPS J; 2021 Dec; 24(1):9. PubMed ID: 34874508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.